Coronavirus and SARS-CoV-2

Coronavirus disease (COVID-19) is a new infection and virulent respiratory disease occurs when virus-containing particles expired by an infected person, either respiratory droplets or aerosols effectuated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an uncommon severe acute respiratory syndrome coronavirus. Although SARS-CoV-2 has a response for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyper inflammation. The virus predominantly spreads between people through close contact and by means of respiratory droplets induced from coughs or sneezes and it mainly enters human cells by binding to the receptor angiotensin converting enzyme 2.

Most common symptoms are:

  • Fever
  • Dry cough
  • Tiredness

Related Conference of Coronavirus and SARS-CoV-2

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
April 05-05, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

Coronavirus and SARS-CoV-2 Conference Speakers

Recommended Sessions

Related Journals

Are you interested in